Oritavancin

Cat. No.: IBDI-434663

Oritavancin (LY 333328) is an orally active glycopeptide antibiotic with activity against gram-positive organisms. Oritavancin shows antibacterial effect against multidrug-resistant S. pneumoniae. Oritavancin inhibits cell wall synthesis and disrupts the membrane potential.

Product Details

Target	Antibiotic | Bacterial
Molecular Weight	1793.10
Synonyms	LY 333328, Orbactiv
SMILES	O[[email protected]@H]1[[email protected]@H](O[[email protected]@](O[[email protected]@H](C)[[email protected]@H]2O)([H])C[[email protected]]2(C)NCC3=CC=C(C4=CC=C(Cl)C=C4)C=C3)[[email protected]@H](O[[email protected]](CO)[[email protected]]1O)OC5=C(OC6=CC=C([[email protected]]([[email protected]]7NC([[email protected]](NC)CC(C)C)=O)O)C=C6Cl)C=C([[email protected]](NC([[email protected]@H](NC7=O)CC(N)=O)=O)([H])C(N[[email protected]](C8=O)([H])C9=CC%10=C(O)C=C9)=O)C=C5OC%11=CC=C([[email protected]]([[email protected]](C(N[[email protected]@](C(O)=O)([H])C%12=C%10C(O)=CC(O)=C%12)=O)([H])N8)O[[email protected]@](O[[email protected]@H](C)[[email protected]@H]%13O)([H])C[[email protected]@]%13(N)C)C=C%11Cl

Storage & Handling

Shipping	Room temperature in continental US. May vary elsewhere.
Storage	Please store the product under the recommended conditions in the Certificate of Analysis.
Regulatory Status	This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use.